Anxiolytic activity of NPY receptor agonists in the conflict test

Psychopharmacology

Volumn 132, Issue 1, 1997, Pages 6-13

  Britton, K T ^a   Southerland, S ^a   Van Uden, E ^a   Kirby, D ^b   Rivier, J ^b   Koob, G ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anxiety; Conflict test; GABAa receptor; Neuropeptide Y

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHLORDIAZEPOXIDE; FLUMAZENIL; ISOPROPYLBICYCLOPHOSPHORIC ACID; NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y [6 GLYCINE 26 GLUTAMIC ACID 29 LYSINE 34 PROLINE]; NEUROPEPTIDE Y [7,21 CYSTEINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR AGONIST; PANCREAS POLYPEPTIDE; PEPTIDE YY; PICROTOXININ RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONFLICT; CONTROLLED STUDY; ELECTRIC SHOCK; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PUNISHMENT; RAT; STRESS; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; GABA MODULATORS; MALE; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y;

EID: 0030832272     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050313     Document Type: Article

References (41)

1. Aoki C, Pickel V (1989) Neuropeptide Y in the cerebral cortex and caudate-putamen nuclei: ultrastructural basis for interactions with GABAergic and non-GABAergic neurons. J Neurosci 9 : 4333-4354
2. Britton KT, Morgan J, Rivier J, Koob G (1985) Chlordiazepoxide attenuates CRF-induced response suppression in the conflict test. Psychopharmacology 86 : 170-174
3. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL (1995) Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6 : 215-222
4. Castagne V, Corder R, Gaillard R, Mormede P (1987) Stress-induced changes in circulating neuropeptide Y in the rat: comparison with catecholamines. Reg Peptides 19 : 55-63
5. Cheng J-T, Chen C-F, Shum A, Wang J-Y, Chen H (1992) Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat. Neurosci Lett 140 : 211-214
6. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL (1985) The anatomy of neuropeptide Y-containing neurons in the rat brain. Neuroscience 15 : 1159-1181
7. Clark, JT, Kalra PS, Crowley WR. Kalra SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115 : 427-429
8. 2 receptor. Br J Pharmacol 102 : 41-44
9. Dumont Y, Fournier A, St-Pierre S, Quirion R (1993) Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13 : 73-86
10. 1 receptor agonist. Proc Natl Acad Sci USA 87 : 182-186
11. Fuxe K, Agnati L, Harfstrand A, Zini I, Tatemoto K, Pich E, Hokfelt V, Mutt V, Terenius L (1983) Central administration of neuropeptide Y induces hypotension, bradypnea and EEG synchronization in the rat. Acta Physiol Scand 118 : 189-192
12. Gehlert DR (1994) Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics. Life Sci 55 : 551-562
13. Grundemar L, Hakanson R (1993) Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms. Gen Pharamacol 24 : 785-796
14. Gue M, Junien J, Del Rio C, Bueno L (1992) Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances through sigma and cholecystokinin receptors. J Pharmacol Exp Ther 261 : 850-855
15. Heilig M (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic actions of NPY in amygdala and paradoxically increases feeding. Regul Peptides 59 : 201-205
16. Heilig M, Murrison R (1987) Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosions in the rat. Eur J Pharmacol 137 : 127-129
17. Heilig M, Soderpalm B, Engel J, Widerlov E (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 94 : 524-529
18. Heilig M, Koob GF, Britton KT (1992) Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides, in an operant conflict test. Reg Peptides 41 : 65-69
19. 1 receptors in the amygdala, and dissociation from food effects. Neuropsychopharmacology 98 : 357-363
20. Heilig M, Koob GF, Ekman R, Britton KT (1994) Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17 : 80-85
21. Hendry S, Jones E, Einson P (1986) Morphology, distribution and synaptic relations of somatostatin and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J Neurosci 100 : 11-22
22. Irwin M, Brown M, Patterson T, Hanger R, Mascovich A, Grant I (1991) Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB 5 : 3100-3107
23. Jewett DC, Levine AS, Cleary J, Schall DW, Thompson T (1989) The effect of intracerebroventricular (ICV) NPY on food reinforced behavioral. Soc Neurosci Abstr 15 : 894
24. Jolicoeur F, Michaud J-N, Rivest R, Menard D, Gaudin D, Fournier A, St-Pierre S (1991) Neurobehavioral profile of neuropeptide Y. Brain Res Bull 26 : 265-268
25. Junien J, Gue M, Bueno L (1991) Neuropeptide Y and sigma ligand (JO 1784) act through Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats. Neuropharmacology 30 : 1119-1124
26. Kirby DA, Koerber SC, Craig AG, Feinstein RD, Delmas L, Brown M, Rivier JE (1993) Defining structural requirements for neuropeptide Y receptors using truncated and conformtionally restricted analogues. J Med Chem 36 : 385-393
27. 1 receptor sub-class. J Med Chem 38 : 4579-4586
28. Klapstein G, Colmers W (1993) On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3 : 103-112
29. Koob GF, Mendelson WB, Schafer J, Wall T, Britton KT, Bloom FE (1989) Picrotoxinin receptor ligand blocks anti-punishment effects of alcohol. Alcohol 5 : 437-443
30. Levine SA, Morley JE (1984) Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5 : 1025-1029
31. Lundberg J, Martinsson A, Hemsen A, Theodorsson-Norheim E, Scendenhag J Ekblom, B Hjemdahl P (1985) Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 133 : 30-36
32. Massari V, Chan J, Chronwall B, O'Donohue T, Pickel V (1988) Neuropeptide Y in the rat nucleus accumbens: ultrastructure, localization and synaptic interaction with GABAergic neurons. J Neurosci Res 19 : 171-186
33. Morris M, Kapoor V, Chalmers J (1987) Plasma neuropeptide Y concentration is increased after hemorrhage in conscious rats: relative contributions of sympathetic nerves and adrenal medulla. J Cardiol Pharmacol 9 : 541-545
34. Pollard GT Howard JL (1990) Effects of drugs on punished behavior: pre-clinical test for anxiolytics. Pharmacol Ther 45 : 403-424
35. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 285 : 417-418
36. Toth PT, Bindokas VP, Bleakman P, Colmers WF, Miller RJ (1993) Mechanisms of presynaptic inhibition of neuropeptide Y at sympathetic nerve terminals. Nature 364 : 635-639
37. Wahlestedt C, Reis DJ (1993) Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 32 : 309-352
38. 1 receptors by antisense oligodeoxynucleotides. Science 259 : 528-530
39. Wettstein J G, Broqua P, Rocher MN, Junien JL (1994) Attenuation of fear-potentiated startle by neuropeptide Y receptor agonists. Neuropeptides 26 : 116-117
40. Wiley JL, Balster RL (1992) Preclinical evaluation of N-methyl-D-aspartate antagonists for antianxiety effect: a review. In: Kamenka JM, Domino EF (eds) Multiple sigma and PCP receptor ligands: mechanisms for neuromodulation and neuroprotection? NPP Books, Ann Arbor, pp 801-815
41. Zukowska-Grojec Z, Shen Z, Capraro P, Vaz C (1991) Cardiovascular, neuropeptide Y and adrenergic responses to stress are sexually differentiated. Physiol Behav 49 : 771-777